Neutralizing antibodies in cats infected with feline immunodeficiency virus.
AUTOR(ES)
Tozzini, F
RESUMO
Sera from cats experimentally infected with five isolates of feline immunodeficiency virus (FIV) from various geographical regions and from FIV enzyme-linked immunosorbent assay-seropositive field cats from four European countries neutralized the Petaluma strain of FIV (FIV-P), originally isolated in California, at high titers. In addition, FIV-P and a European isolate proved equally susceptible to neutralization by all sera tested. Coupled with observations by Fevereiro et al. (M. Fevereiro, C. Roneker, A. Laufs, L. Tavares, and F. de Noronha, J. Gen. Virol. 72:617-622, 1991), these findings indicate that most if not all FIV strains circulating in Europe and the United States share important neutralization-inducing epitopes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=265592Documentos Relacionados
- Detection of salivary antibodies in cats infected with feline immunodeficiency virus.
- Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.
- Sleep patterns are disturbed in cats infected with feline immunodeficiency virus.
- Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.
- Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus.